Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Hartmann

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Experimental Brain Research|December 20, 2011
The role of APP proteolytic processing in lipid metabolismMarcus O W Grimm, Tatjana L Rothhaar, Tobias Hartmann
Trends in Molecular Medicine|July 24, 2007
Amyloid beta as a regulator of lipid homeostasisMarcus O W Grimm, Heike S Grimm, Tobias Hartmann
Journal of Lipid Research|May 22, 2017
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia preventionMarcus O W Grimm, Daniel M Michaelson, Tobias Hartmann
Biochimica Et Biophysica Acta|May 11, 2010
Role of amyloid beta in lipid homeostasisSven Grösgen, Marcus O W Grimm, Petra Friess, et al.
Frontiers in Molecular Neuroscience|March 28, 2017
APP Function and Lipids: A Bidirectional LinkMarcus O W Grimm, Janine Mett, Heike S Grimm, et al.
Statistics in Medicine|May 18, 2022
Modeling the underlying biological processes in Alzheimer's disease using a multivariate competing risk joint modelFloor M van Oudenhoven, Sophie H N Swinkels, Tobias Hartmann, et al.
Neurobiology of Disease|June 17, 2006
Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neuronsAnja Schneider, Walter Schulz-Schaeffer, Tobias Hartmann, et al.
Neurobiology of Aging|February 19, 2005
Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42Marco Duering, Marcus O W Grimm, Heike S Grimm, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
Radioiodine therapy of benign thyroid-disordersTobias Hartmann, Werner Vach, Lars Frings, et al.
International Journal of Geriatric Psychiatry|February 11, 2011
Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depressionNicholas A Clarke, Tobias Hartmann, Emma L Jones, et al.
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Experimental Brain Research|December 20, 2011
The role of APP proteolytic processing in lipid metabolismMarcus O W Grimm, Tatjana L Rothhaar, Tobias Hartmann
Trends in Molecular Medicine|July 24, 2007
Amyloid beta as a regulator of lipid homeostasisMarcus O W Grimm, Heike S Grimm, Tobias Hartmann
Journal of Lipid Research|May 22, 2017
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia preventionMarcus O W Grimm, Daniel M Michaelson, Tobias Hartmann
Biochimica Et Biophysica Acta|May 11, 2010
Role of amyloid beta in lipid homeostasisSven Grösgen, Marcus O W Grimm, Petra Friess, et al.
Frontiers in Molecular Neuroscience|March 28, 2017
APP Function and Lipids: A Bidirectional LinkMarcus O W Grimm, Janine Mett, Heike S Grimm, et al.
Statistics in Medicine|May 18, 2022
Modeling the underlying biological processes in Alzheimer's disease using a multivariate competing risk joint modelFloor M van Oudenhoven, Sophie H N Swinkels, Tobias Hartmann, et al.
Neurobiology of Disease|June 17, 2006
Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neuronsAnja Schneider, Walter Schulz-Schaeffer, Tobias Hartmann, et al.
Neurobiology of Aging|February 19, 2005
Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42Marco Duering, Marcus O W Grimm, Heike S Grimm, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
Radioiodine therapy of benign thyroid-disordersTobias Hartmann, Werner Vach, Lars Frings, et al.
International Journal of Geriatric Psychiatry|February 11, 2011
Antipsychotic medication is associated with selective alterations in ventricular cerebrospinal fluid Aβ 40 and tau in patients with intractable unipolar depressionNicholas A Clarke, Tobias Hartmann, Emma L Jones, et al.
Pageof 13